Robert E. Schwartz

7 ta ish

Autonomix Medical (United States)

1. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

   Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu +12

   MaqolaOAOchiq kirish20206 iqtibos

   ABIABI:AkademIndex/2026.other.210932

2. Targeting potential drivers of COVID-19: Neutrophil extracellular traps

   Betsy Barnes, José M. Adrover, Amelia Baxter-Stoltzfus +20

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.210931

3. Evolution of antibody immunity to SARS-CoV-2

   Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi +39

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.373865

4. TCT-571 Pain Mitigation in Pancreatic Adenocarcinoma: A Long-Term Analysis of Denervation via Transvascular RF Energy-Based Ablation

   Askar Sabirov, Robert E. Schwartz, Elizabeth Wilkirson +2

   Boshqa20260 iqtibos

   ABIABI:AkademIndex/2026.other.f3733zxb

5. 200.29 Catheter-Based Transvascular RF Neural Ablation for Severe Pancreatic Cancer Pain: First Results From the ELPIS Study

   Robert E. Schwartz, Askar Sabirov

   MaqolaOAOchiq kirishCardiac Arrhythmias and TreatmentsJACC: Cardiovascular Interventions20250 iqtibos

   ABIABI:AkademIndex/2025.article.003786

6. TCT-576 Pain Mitigation in Pancreatic Adenocarcinoma: An Analysis of Denervation via Transvascular RF Energy-Based Ablation

   Askar Sabirov, Robert E. Schwartz, Brad Hauser

   MaqolaOAOchiq kirishDiamond and Carbon-based Materials ResearchJournal of the American College of Cardiology20250 iqtibos

   ABIABI:AkademIndex/2025.article.009292

7. Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation.

   Robert E. Schwartz, Askar Sabirov, Clarke Wilkirson

   MaqolaOAOchiq kirishPain Management and Opioid UseJournal of Clinical Oncology20260 iqtibos

   ABIABI:AkademIndex/2026.article.000982